Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cooper

Showing results (321-330 of 324) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 324 results.
The Lancet. HIV|October 22, 2018
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort studyAndrew E Grulich, Rebecca Guy, Janaki Amin, et al.
Ebiomedicine|April 3, 2017
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International CollaborationSoo-Yon Rhee, Vici Varghese, Susan P Holmes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infectionVignesh N Hariharan, Minwook Shin, Ching-Wen Chang, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 33

Showing results (321-330 of 324) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 324 results.
The Lancet. HIV|October 22, 2018
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort studyAndrew E Grulich, Rebecca Guy, Janaki Amin, et al.
Ebiomedicine|April 3, 2017
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International CollaborationSoo-Yon Rhee, Vici Varghese, Susan P Holmes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infectionVignesh N Hariharan, Minwook Shin, Ching-Wen Chang, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 33